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Abstract
Background: Obstructive sleep apnea (OSA) is a common disorder that affects 5% of the
adult North American population. It is associated with atrial arrhythmias and stroke. The
mechanisms of this association remain unclear. The aim to the study was to identify the
factors associated with interatrial block (IAB) among patients with OSA.
Methods: Patients referred for polysomnography were studied. Sleep apnea severity (apnea-
-hypopnea index [AHI]) was measured in each subject. 12-lead ECGs were scanned and
amplified (× 10); P-wave duration and dispersion were measured using a semi-automatic
caliper. IAB was defined as a P-wave duration ≥ 120 ms.
Results: Data from 180 consecutive patients was examined. Moderate-severe OSA (mean
AHI = 56.2 ± 27.9) was present in 144 (OSA group). The remaining 36 had mild or no OSA
(mean AHI = 5.6 ± 3.6) and were used as controls. Age distribution between the groups did
not differ and there were more males in the OSA group (69.4% vs 47.2%, p = 0.01). Obesity
(78.5% vs 39.4%, p < 0.001) and hypertension (51.4% vs 27.8%, p < 0.01) were more
prevalent in the OSA group. IAB was more prevalent in patients with moderate-severe OSA
(34.7% OSA vs 0% controls, p < 0.001). In linear regression, age and AHI > 30 were
independent predictors of maximum P-wave duration (p = 0.001 and p < 0.001, respectively).
P-wave dispersion was significantly higher in the severe OSA group (14.6 ± 7.5 for OSA, 8.9 ±
± 3.1 controls, p < 0.001).
Conclusions: Older age and moderate-severe OSA are predictors of IAB. P-wave dispersion
is increased in patients with moderate-severe OSA. This may partly explain the high preva-
lence of atrial arrhythmias in patients with OSA. (Cardiol J 2011; 18, 2: 171–175)
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Introduction
Obstructive sleep apnea syndrome (OSA) is
a common breathing disorder that affects 5% of the
North American adult population, with men being
affected almost twice as much as women [1]. The
condition has well defined associations with in-
creased cardiovascular morbidity and mortality,
arrhythmia, daytime hypersomnolence, motor ve-
hicle accidents and neurocognitive dysfunction; but
despite this it is grossly under diagnosed [2–6].
Atrial fibrillation (AF) is strongly associated with
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OSA [7]. In addition, patients with untreated OSA
are at higher risk for AF recurrence after electrical
cardioversion [8].
Interatrial block (IAB) is prevalent in the po-
pulation at large, in particular in those over 65 years
of age [9–12]. Abnormal atrial depolarization is re-
ferred to as IAB when the P-wave is ≥ 110 ms which
signifies excessive time for sinus impulses to con-
duct from the right atrium (RA) to the left atrium
(LA) [13]. LA conduction that results in (delayed)
LA activation in IAB is thought to principally occur
in the region of the atrioventricular node, where
a caudocranial (‘upward’) deflection of the preced-
ing RA-descending sinus impulses then occurs [14].
The conduction delay between the RA and LA is
depicted on the electrocardiogram (ECG) as pro-
longed, often bifid (‘notched’) P-waves with distinc-
tive RA and LA components [15–18].
Several pathophysiological mechanisms have
been involved in the link between OSA and AF, such
as increased sympathetic tone, hypertension, obe-
sity (a co-morbidity that is frequent for both condi-
tions) and increased pulmonary pressure [19, 20].
However, the prevalence of IAB, an accepted risk
factor for AF, in patients with OSA, has only been
reported in a small study [21].
Our hypothesis is that IAB is commoner among
patients with OSA than in those with less severe, or
no, OSA. We designed this study to determine the
association between severity of OSA and P-wave
prolongation, and to compare P-wave dispersion be-
tween patients with and without severe OSA.
Methods
We analyzed 180 patients referred for over-
night polysomnography study at the Sleep Labora-
tory at Kingston General Hospital. Demographics
and the results of the polysomnographic study col-
lected included: age, gender, obesity, systemic hy-
pertension, coronary artery disease (CAD), diabe-
tes mellitus (DM), heart failure, apnea/hypopnea
index (AHI), and maximum oxygen desaturation.
Apnea was defined as a cessation of the airflow with
O2 saturation reduction > 4%. Consent was not
required as the analysis was done retrospectively.
We obtained Internal Review Board approval from
our institution.
Polysomnography
Standard overnight polysomnography was per-
formed on all patients. This included four EEG chan-
nels (two central: C3–A2, C4–A1, and two occipital:
O2–A1, O1–A2), two EOG channels, submental
EMG, finger pulse oximetry, modified lead II ECG,
thoracic and abdominal movement (piezoelectric
bands), right and left anterior tibialis EMG, diaphra-
gmatic surface EMG, and snore vibration sensor. Air-
flow was measured with both a nasal cannula pres-
sure transducer and oral thermistor. The record-
ing duration was seven hours or the patient’s usual
time in bed. OSA was considered moderate-severe
when AHI ≥ 25 episodes per hour, and considered
not present when AHI was < 5 episodes per hour.
ECG measurements
The 12-lead ECGs were recorded at 25.0 mm/s,
10 mm/mV and 150 Hz; and scanned at 300 DPI.
For measuring intervals we used a semi-automatic
caliper (Iconico, New York, USA) amplifying the
ECG ten times. ECGs were measured by two in-
vestigators. In case of disagreement, the ECG was
blinded and interpreted by an expert electrophysio-
logist (AB, DR, CS). The onset of the P-wave was
defined as the point of initial upward or downward
deflection calculated from baseline. The P-wave
offset was the returning point of the waveform to
baseline.
IAB was defined as a P-wave duration ≥ 120 ms
to facilitate ECG measurement. P-wave dispersion
was calculated as max. P-wave–min. P-wave. Pa-
tients with implantable devices and without read-
able ECGs were excluded from the analysis.
Statistical analysis
Data was entered into an Excel spreadsheet
designed for this study and imported into SPSS Ver-
sion 17.0 for Windows (2008) for statistical analysis.
Frequencies and proportions were generated for all
categorical data, and means, medians and standard
deviations were calculated for the continuous data.
These descriptive analyses provided the prevalence
of IAB in the sample. Demographic and clinical char-
acteristics of those with moderate-severe OSA were
compared to those with no OSA using c2 tests (cate-
gorical data) and t-tests (continuous data). The rela-
tionship between maximum P-wave duration and age
was assessed by means of Pearson correlation. Li-
near regression modeling was used to assess the as-
sociation between OSA status and maximum P-wave
duration while controlling for age.
Results
Demographic and clinical characteristics, and
results of the polysomnography, are shown in
Table 1. Moderate-severe OSA (mean AHI 56.2 ±
± 27.9) was present in 144 patients (OSA group).
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The remaining 36 patients had mild or no OSA
(mean AHI = 5.6 ± 3.6) and were used as controls
(control group). No patients were taking antiar-
rhythmic drugs. Age distribution between the two
groups did not differ (56.7 ± 12.6 years for OSA,
56.4 ± 12.4 years for controls, p = 0.9), and there
were more males in the OSA group (69.4% vs
47.2%, p = 0.01). Obesity and hypertension were
more prevalent in the OSA group (78.5% vs 39.4%,
p < 0.001 and 51.4% vs 27.8%, p < 0.01, respec-
tively). CAD, DM and heart failure tended to be
more prevalent in patients with OSA also, but the
differences did not reach statistical significance. LA di-
mensions measured by two-dimensional echocardio-
gram (antero-posterior) showed a larger diameter in
the OSA group (40.8 ± 7 mm vs 34.6 ± 4.8 mm;
p = 0.03).
The prevalence of IAB in patients with and
without moderate-severe OSA can be seen in Ta-
ble 2.
IAB was more prevalent in patients with mod-
erate-severe OSA (34.7% OSA vs 0% controls, p <
0.001). In linear regression, age and AHI > 25 were
independent predictors of max. P-wave duration
(p = 0.001 and p < 0.001, respectively). CAD, ar-
terial hypertension, obesity and minimum satura-
tion did not predict IAB in the linear regression
model. The P-wave was prolonged by 1.8 ms for
each decade of age, and by 7.6 ms for the OSA group
compared to the control group. Max. P-wave dura-
tion correlated with the severity of OSA (Fig. 1, r =
= 0.195, p = 0.009). P-wave dispersion was signi-
ficantly higher in the moderate-severe OSA group
(14.6 ± 7.5 vs 8.9 ± 3.1, p < 0.001).
Table 2. Interatrial block and P-wave dispersion in patients with and without obstructive sleep apnea
(OSA).
Moderate-severe OSA (AHI > 25) Control group P
Interatrial block (%) 34.7 0 < 0.001
P-wave dispersion [ms] 14.6 ± 7.5 8.9 ± 3.1 < 0.001
Table 1. Demographic and clinical characteristics and polysomnography results.
Moderate-severe obstructive Control group P
sleep apnea (AHI > 25)
Age (years) 56.7 ± 12.6 56.4 ± 12.4 0.90
Gender (male, %) 69.4 47.2 0.01
Hypertension (%) 51.4 27.8 < 0.01
Obesity (%) 78.5 39.4 < 0.001
Heart failure (%) 17.6 5.6 0.12
Coronary artery disease (%) 30.1 16.7 0.11
Diabetes mellitus (%) 30.8 22.2 0.31
Left atrium dimension [mm] 40.8 ± 7 34.6 ± 4.8 0.038
Apnea/hypopnea index (AHI) 56.2 ± 27.9 5.6 ± 3.6 < 0.001
Maximum desaturation (%) 79.8 88.4 < 0.001
Figure 1. Correlation between obstructive sleep apnea
and max. P-wave duration. Correlation coefficient is 0.195,
p = 0.009.
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Discussion
The main findings of our study were that IAB
(clinically defined as P-wave duration > 120 ms)
was highly prevalent in an unselected population
with moderate-severe OSA; that IAB was signifi-
cantly more frequent in patients with moderate-
severe OSA than in patients with no or mild OSA;
and that P-wave dispersion was significantly in-
creased in patients with moderate-severe OSA. The
severity of OSA, determined by an AHI > 25, cor-
related with the longer P-wave duration. This may
indicate the presence of atrial electrical remodel-
ing in patients with moderate-severe OSA. How-
ever, one should be cautious in interpreting these
results because when the AHI is between 0 and 15,
all P-wave durations were normal (below 120 ms),
and in patients with an AHI > than 25, about one
third presented a P-wave longer than 120 ms.
Whereas the correlation coefficient between OSA
and P-wave duration may statistically be correct, in
view of the large variations in P-wave duration, in
individual cases the correlation could be clinically
less relevant.
A previous study [21] found similar results in
a smaller population and using manual calipers. In
that study, the OSA was less severe than in our
study, but still showed that patients with AHI > 30
had an increased P-wave duration and dispersion in
comparison to no OSA. Surprisingly, in the Can et
al. study [21] the LA dimension between the three
populations (mild, moderate and severe OSA) did
not differ; indicating that the electrical atrial remo-
deling could be an independent phenomenon not
necessarily related to structural atrial remodeling.
Our findings showed that the LA dimension was
increased in the group with moderate-severe OSA,
making the presumption of electrical atrial remo-
deling as an independent phenomenon less likely.
The association between OSA and AF has been
previously reported. A sub-study of the Sleep
Health Heart Health Study [22] showed a four-fold
increased AF prevalence in patients with severe
OSA using the ECG recordings of the polysomnog-
raphy, which could underestimate the ‘true’ preva-
lence of AF in this population [23]. Gami et al. [7]
demonstrated, using a validated tool for the screen-
ing of OSA (Berlin Questionnaire), a strong associ-
ation between AF and OSA. Our group showed that
the presence of intermittent interatrial block after
a successful cardioversion could be a predictor of
early AF recurrence [24]. Despite this well-de-
monstrated association, the mechanisms that link the
two conditions remain somewhat unclear [25, 26].
However, some observations can be made. OSA
produces an autonomic nervous system imbalance
with increased sympathetic tone [19, 20]. System-
ic and pulmonary hypertension are common and
both may impact on atrial stretching, inducing struc-
tural atrial remodeling and loss of normal atrial ar-
chitecture [27]. In addition, intermittent chronic
hypoxemia, hypercapnia and increased plasmatic
catecholamine levels may represent a direct pro-
arrhythmogenic injury to the atrial tissue.
Increased P-wave duration in the surface ECG
may be a manifestation of atrial electrical remodel-
ing. In our study, P-wave duration in patients with
moderate-severe OSA was significantly longer than
in patients with no OSA. Additionally, the severity
of the OSA correlated positively with a prolonga-
tion of the P-wave duration. AHI > 25 and older age
were independent predictors of maximum P-wave
duration.
Not surprisingly, P-wave dispersion was also
increased in patients with moderate-severe OSA.
Is the atrial electrical remodeling induced by
OSA the explanation for the frequent association
between OSA and AF?
Both IAB and increased P-wave dispersion
have been found to be predictors of AF in different
clinical scenarios than OSA [10, 17, 18]. It is possi-
ble that OSA-related IAB could be a manifestation
of atrial electrical remodeling that facilitates AF
development, maintenance and/or recurrence.
Limitations of the study
Although IAB is considered a risk factor for AF,
the lack of follow-up in this study does not allow
evaluating the clinical relevance of increased
P-wave dispersion and, specifically, whether the
presence of IAB confers a higher risk of develop-
ing AF in this population.
Conclusions
Interatrial block is significantly more prevalent
in patients with moderate-severe OSA than in con-
trols. Age and severity of OSA are independent pre-
dictors of maximum P-wave duration. P-wave dis-
persion is increased in patients with moderate-
-severe OSA. Further studies are needed to confirm
whether IAB in patients with OSA is associated with
AF development or recurrence.
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